Home - Invivoscribe

Invivoscribe-Shop-Product-Availability-Key-1920×160-Image-2x-001

Invivoscribe-Shop-Product-Availability-Key-Image-2x-002

All Products

Cat #: K4120361
LeukoStrat^® CDx FLT3 Mutation Assay
The LeukoStrat® CDx FLT3 Mutation Assay is the companion diagnostic to both RYDAPT® (midostaurin) and XOSPATA® (gilteritinib) in the United States ...
View Product
Cat #: COVID-19-6-TK
COVID-19 (6) Test Kit
This is a (6) sample, Testing Service. Six Collection Devices are included in the cost of this Testing Service and will be shipped to the customer upo...
View Product
Cat #: COVID-19
COVID-19 Test
COVID-19 testing is performed with real-time reverse transcription polymerase chain reaction (RT-PCR) to detect nucleic acid from SARS-CoV-2. Results ...
View Product
Cat #: 40880108
LymphoTrack^® T-Cell Low Positive Control
Minimal Residual Disease (MRD) testing is a valuable tool that allows investigators to study and monitor multiple myeloma (MM), chronic lymphocytic le...
View Product
Cat #: 40880128
LymphoQuant^® T-Cell Internal Control
LymphoQuant T-cell Internal Controls may be spiked into specimens to estimate the respective number of clonotype T-cell equivalents present. Addition ...
View Product
Cat #: 60970100
EagleTaq DNA Polymerase
EagleTaq is the gold standard of hot start polymerases and has demonstrated robust performance in many Invivoscribe assays, including our Minimal Resi...
View Product
Cat #: 40880118
LymphoQuant^® B-Cell Internal Control
LymphoQuant B-cell Internal Controls may be spiked into specimens to estimate the respective number of clonotype B-cell equivalents present. Addition ...
View Product
Cat #: 40880098
LymphoTrack^® B-Cell Low Positive Control
Minimal Residual Disease (MRD) testing is a valuable tool that allows investigators to study and monitor multiple myeloma (MM) , chronic lymphocytic l...
View Product
Cat #: 91010020
IdentiClone^® IGH Gene Clonality Assay – Gel Detection
Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...
View Product
Cat #: FLT3-CDx
LeukoStrat^® CDx FLT3 Mutation Assay
The fms related tyrosine kinase 3 (FLT3) is one of the most commonly mutated genes in acute myeloid leukemia (AML), occurring in approximately 30% o...
View Product
Cat #: 71210149
LymphoTrack^® IGH FR1 Assay Panel B – MiSeq®
The Invivoscribe portfolio of LymphoTrack® IGH – MiSeq® Assays represent a significant improvement over existing clonality assays using fragmen...
View Product
Cat #: MyAML® - CLIA
MyAML^® 194 targeted NGS gene panel – CLIA
It is becoming increasingly evident that understanding the clonal architecture of AML patients is vital for successful treatments. It is likely that m...
View Product
Cat #: 23090060
BCL2/JH Tube B – Unlabeled
Master mixes are components of complete assays. Master mixes are composed of a buffered magnesium solution, deoxynucleotides, and multiple primers tha...
View Product
Cat #: 23090050
BCL2/JH Tube A – Unlabeled
Master mixes are components of complete assays. Master mixes are composed of a buffered magnesium solution, deoxynucleotides, and multiple primers tha...
View Product
Cat #: 13090040
BCL2/JH Translocation Assay MegaKit – Gel Detection
SUMMARY: Invivoscribe’s Gene Rearrangement and Translocation Assays represent a new approach to PCR-based clonality testing. These standardized ...
View Product
Cat #: 13090030
BCL2/JH t(14;18) Translocation Assay MegaKit – Gel Detection
BACKGROUND: BCL2 translocations are reciprocal chromosome exchanges that place the bcl-2 proto-oncogene, located on chromosome 18, under aberrant tran...
View Product
Cat #: 23090020
BCL2/JH t(14;18) (mcr) Mix 2b – Unlabeled
Master mixes are components of complete assays. Master mixes are composed of a buffered magnesium solution, deoxynucleotides, and multiple primers tha...
View Product
Cat #: 12070101
T-Cell Receptor Gamma Gene Rearrangement Assay 2.0 – ABI Fluorescence Detection
SUMMARY: Invivoscribe’s T Cell Receptor Gamma Gene Rearrangement Assay 2.0 represents an improved approach to PCR-based clonality testing of T-cell ...
View Product
Cat #: A3090070
BCL2/JH mcr – Unlabeled
This product targets the human BCL2/JH fusion gene. ...
View Product
Cat #: 12070051
T-Cell Receptor Gamma Gene Rearrangement Assay – ABI Fluorescence Detection
SUMMARY: Invivoscribe’s Gene Rearrangement Assays represent a new approach to PCR-based testing. These assays utilize a series of standardized ...
View Product

Invivoscribe provides a full range of standardized CE-marked in vitro diagnostic cGMP products for hematology-oncology, as well as RUO assays, analyte specific reagents (ASRs), and DNA & RNA controls.

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

CORONAVIRUS COVID-19 TESTING

Performed with real-time reverse transcription polymerase chain reaction (RT-PCR) to detect nucleic acid from SARS-CoV-2.

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

March 21st, 2019
Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms

August 25th, 2018
A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations

August 22nd, 2018
Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL

Territory

Detection

Regulatory Classification

Locus Target

Application

Product Type

Box Type

Design

Size

All Products

Coming Soon

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Coming Soon

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Invivoscribe provides a full range of standardized CE-marked in vitro diagnostic cGMP products for hematology-oncology, as well as RUO assays, analyte specific reagents (ASRs), and DNA & RNA controls.

The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

CORONAVIRUS COVID-19 TESTING Performed with real-time reverse transcription polymerase chain reaction (RT-PCR) to detect nucleic acid from SARS-CoV-2.

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

March 21st, 2019 Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms

August 25th, 2018 A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations

August 22nd, 2018 Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL

Territory

Detection

Regulatory Classification

Locus Target

Application

Product Type

Box Type

Design

Size

All Products

Coming Soon

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Coming Soon

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

CORONAVIRUS COVID-19 TESTING

Performed with real-time reverse transcription polymerase chain reaction (RT-PCR) to detect nucleic acid from SARS-CoV-2.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

March 21st, 2019
Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms

August 25th, 2018
A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations

August 22nd, 2018
Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL